Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | PL2 - Hot Topics Plenary Session

Saturday 04/22/23
05:00 PM - 06:00 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Plenary Session
Antonio M. P. Omuro, MD, FAAN
General Neurology, Aging, Dementia, Cognitive, and Behavioral Neurology, Epilepsy/Clinical Neurophysiology (EEG), Movement Disorders, Neuromuscular and Clinical Neurophysiology (EMG)
This session features the latest, cutting-edge translational research related to clinical issues of importance. Three outstanding speakers provide summaries of their recent research findings and describe the clinical implications of the results.
1.00 CME credit
Patient Care & Procedural Skills, Medical Knowledge
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Didactic

Program Materials Program Evaluations

Event Timeline
05:00 PM - 05:17 PM EST Speaker Artificial Intelligence Applications in Neurology: Seizing the Moment
Kathryn A. Davis, MD
05:17 PM - 05:34 PM EST Speaker Biological Vulnerability Factors in Functional Neurologic Disorders
Selma Aybek, MD, FAAN
05:34 PM - 05:51 PM EST Speaker CRISPR Therapy Revolution
Cathleen Lutz, PhD, MBA
Faculty Disclosures
Antonio M. P. Omuro, MD, FAAN Dr. Omuro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Omuro has received personal compensation in the range of $0-$499 for serving as a Consultant for Kiyatec. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pyramid. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curevac. Dr. Omuro has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Opinion in Neurology. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Agios. The institution of Dr. Omuro has received research support from Arcus Biosciences. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Denovo Biopharma.
Kathryn A. Davis, MD Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals/Jazz Pharmaceuticals. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UNEEG. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia Open. Dr. Davis has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Davis has received research support from Eisai. The institution of Dr. Davis has received research support from Liminal. Dr. Davis has received publishing royalties from a publication relating to health care.
Selma Aybek, MD, FAAN Dr. Aybek has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Swiss Movement Disorder Foundation. The institution of Dr. Aybek has received research support from Swiss National Science Foundation.
Cathleen Lutz, PhD, MBA No disclosure on file